Penumbra, Inc.
United States
198 articles about Penumbra, Inc.
-
Despite the changing landscape in biopharma, many companies are still recruiting. If you’re looking to make a career change, here are 12 biopharma companies hiring on BioSpace now.
-
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
2/22/2024
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2023.
-
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024
2/1/2024
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2023 after market close on Thursday, February 22, 2024 at 4:30 PM Eastern Time.
-
Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference
12/18/2023
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on Monday, January 8, 2024.
-
First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary Embolism
11/28/2023
Penumbra, Inc. announced the first patient enrolled in STORM-PE, a first-of-its-kind prospective, multi-center, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus Lightning Flash™ for the treatment of pulmonary embolism (PE).
-
Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
11/14/2023
Penumbra, Inc. announced that its management team is scheduled to present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.
-
Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023
10/5/2023
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2023 after market close on Thursday, November 2, 2023 at 4:30 PM Eastern Time.
-
Penumbra, Inc. to Present at Upcoming September 2023 Investor Conferences
8/23/2023
Penumbra, Inc. announced that its management team is scheduled to present at the following investor conferences.
-
Penumbra, Inc. Reports Second Quarter 2023 Financial Results
8/1/2023
Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the second quarter ended June 30, 2023.
-
Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference
7/26/2023
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023.
-
Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023
7/5/2023
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2023 after market close on Tuesday, August 1, 2023 at 4:30 PM Eastern Time.
-
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
6/1/2023
Penumbra, Inc. announced the U.S. Food and Drug Administration clearance and launch of Lightning Bolt™ 7, the most advanced and powerful arterial thrombectomy system on the market.
-
Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference
5/24/2023
Penumbra, Inc. announced that its management team is scheduled to present at William Blair's 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023.
-
Penumbra, Inc. Reports First Quarter 2023 Financial Results
5/2/2023
Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the first quarter ended March 31, 2023.
-
Penumbra, Inc. to Present at Upcoming April 2023 Investor Conferences
4/25/2023
Penumbra, Inc. announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below.
-
Penumbra, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 2, 2023
4/4/2023
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023 at 4:30 PM Eastern Time.
-
Penumbra, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
2/23/2023
Penumbra, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022.
-
Penumbra, Inc. to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference
2/16/2023
Penumbra, Inc. announced that its management team is scheduled to present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference on Thursday, March 2, 2023.
-
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023
1/26/2023
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2022 after market close on Thursday, February 23, 2023 at 4:30 PM Eastern Time.
-
Penumbra Launches Latest Innovation in Mechanical Thrombectomy: Lightning Flash™
1/10/2023
Penumbra, Inc., a global healthcare company focused on innovative therapies, announced the U.S. Food and Drug Administration clearance and launch of Lightning Flash™, the most advanced and powerful mechanical thrombectomy system on the market.